Extracorporeal photopheresis in Sézary syndrome

Lancet. 1997 Sep 20;350(9081):886. doi: 10.1016/S0140-6736(05)62067-3.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Combined Modality Therapy
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use
  • Photopheresis*
  • Recombinant Proteins
  • Sezary Syndrome / drug therapy*
  • Sezary Syndrome / therapy
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / therapy

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins